The Board of Directors of Reneo Pharmaceuticals, Inc. has authorized a buyback plan on October 30, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.645 USD | -0.32% |
|
-3.82% | +2.79% |
May. 16 | Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing | MT |
May. 13 | Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.79% | 55.14M | |
+33.84% | 52.85B | |
-6.79% | 38.87B | |
+34.86% | 38.24B | |
-11.12% | 26.79B | |
+12.18% | 26.16B | |
-19.46% | 19.9B | |
+38.17% | 13.18B | |
+29.84% | 12.24B | |
-3.30% | 11.79B |
- Stock Market
- Equities
- RPHM Stock
- News Reneo Pharmaceuticals, Inc.
- Reneo Pharmaceuticals, Inc. authorizes a Buyback Plan.